Exercise and Weight Control
Primary Purpose
Overweight, Obese
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise Energy Expenditure 300 kcal/day
Exercise Energy Expenditure 600 kcal/day
Sponsored by
About this trial
This is an interventional other trial for Overweight focused on measuring obese, overweight, exercise, energy expenditure differences, relative reinforcing values (RRV), food, physical activity, biological, neurobehavioral, behavioral
Eligibility Criteria
Inclusion Criteria:
- 18 to 40 years old
- BMI of 25.0 - 35 kg/m2
- willing to consent to study conditions
- not taking medications that affects energy expenditure or eating
- not using tobacco or nicotine products
- no food allergies or limitations to eating certain food that would prohibit them from eating the study foods
- not be dieting to lose weight
- no major health problems
- cannot have known cardiovascular, pulmonary or metabolic disease
- cannot be regularly exercising in an aerobic manner more than twice per week
- must have a liking of at least 5 out of 10 for 75% of the study foods
Exclusion Criteria:
- < 18 or > 40 years old
- BMI < 25 or >35 kg/m2
- currently pregnant or trying to become pregnant, or lactating
- currently using tobacco or nicotine
- taking medication that affects energy expenditure or eating
- food allergies to foods used in the study
- regularly exercising in an aerobic manner more than twice per week
- major health problems
Sites / Locations
- USDA Grand Forks Human Nutrition Reserach Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Exercise Energy Expenditure 300 kcal/day
Exercise Energy Expenditure 600 kcal/day
Arm Description
Subjects will be randomly assigned to this group and will exercise energy expenditure of 300 kcal/day.
Subjects will be randomly assigned to this group and will exercise energy expenditure of 600 kcal/day.
Outcomes
Primary Outcome Measures
Negative Energy Balance as assessed by changes in adipose tissue
Whether participants were able to maintain a negative energy balance will be assessed by pre-post changes in stored adipose tissue, as assessed by a dual-energy x-ray absorptiometry scan (DEXA).
Secondary Outcome Measures
Change in relative reinforcing value (RRV) of food
RRV of food will be assessed by evaluating the number of responses (mouse button presses) a participant is willing to complete to gain access to food or an alternative sedentary activity.
Average daily calories consumed as assessed by dietary recall
On two weekdays and one weekend day, participants will fill out the Automated Self-Administered 24-Hour Dietary Recall (ASA24) to estimate dietary intake (total energy, grams carbohydrates, fat, protein, alcohol).
Pre-post intervention changes in Ghrelin plasma levels
Participants will provide a fasting blood sample collected in ethylenediaminetetraacetic acid (EDTA)-coated and serum tubes. Changes in acylated Ghrelin will be measured via enzyme-linked immunosorbent assay (ELISA).
Pre-post intervention changes in glucagon-like peptide 1 (GLP-1) plasma levels
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in GLP-1 concentrations will be measured via ELISA.
Pre-post intervention changes in Ghrelin concentrations
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in Ghrelin concentrations will be measured via ELISA.
Pre-post intervention changes in irisin concentrations
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in irisin concentrations will be measured via ELISA.
Pre-post intervention changes in myostatin plasma levels
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in myostatin levels will be measured via ELISA.
Change in relative reinforcing value (RRV) of physical activity
RRV of physical activity will be assessed by evaluating the number of responses (mouse button presses) a subject is willing to complete to gain access to physical activity or a sedentary alternative.
Change in minutes of sedentary behavior, as assessed by activity tracker
Minutes of sedentary behavior (non-exercise activity) will be assessed by having participants wear an Actigraph accelerometer for 7 days (minimum 10 hours per day) on the right hip.
Full Information
NCT ID
NCT02152501
First Posted
May 22, 2014
Last Updated
July 18, 2019
Sponsor
USDA Grand Forks Human Nutrition Research Center
1. Study Identification
Unique Protocol Identification Number
NCT02152501
Brief Title
Exercise and Weight Control
Official Title
Exercise and Weight Control: A Search for Biological and Neurobehavioral Compensatory Mechanisms That Defend Against Exercise-Induced Negative Energy Balance
Study Type
Interventional
2. Study Status
Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
April 2016 (Actual)
Primary Completion Date
November 2016 (Actual)
Study Completion Date
January 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
USDA Grand Forks Human Nutrition Research Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to research the effects of exercise on calories eaten and expended. The investigator expects to find out whether subjects change their eating and activity behaviors when starting an exercise program.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight, Obese
Keywords
obese, overweight, exercise, energy expenditure differences, relative reinforcing values (RRV), food, physical activity, biological, neurobehavioral, behavioral
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
29 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Exercise Energy Expenditure 300 kcal/day
Arm Type
Experimental
Arm Description
Subjects will be randomly assigned to this group and will exercise energy expenditure of 300 kcal/day.
Arm Title
Exercise Energy Expenditure 600 kcal/day
Arm Type
Experimental
Arm Description
Subjects will be randomly assigned to this group and will exercise energy expenditure of 600 kcal/day.
Intervention Type
Other
Intervention Name(s)
Exercise Energy Expenditure 300 kcal/day
Intervention Type
Other
Intervention Name(s)
Exercise Energy Expenditure 600 kcal/day
Primary Outcome Measure Information:
Title
Negative Energy Balance as assessed by changes in adipose tissue
Description
Whether participants were able to maintain a negative energy balance will be assessed by pre-post changes in stored adipose tissue, as assessed by a dual-energy x-ray absorptiometry scan (DEXA).
Time Frame
End Training (weeks 10-12)
Secondary Outcome Measure Information:
Title
Change in relative reinforcing value (RRV) of food
Description
RRV of food will be assessed by evaluating the number of responses (mouse button presses) a participant is willing to complete to gain access to food or an alternative sedentary activity.
Time Frame
Pre-intervention (week 0) and End Training (weeks 10-12)
Title
Average daily calories consumed as assessed by dietary recall
Description
On two weekdays and one weekend day, participants will fill out the Automated Self-Administered 24-Hour Dietary Recall (ASA24) to estimate dietary intake (total energy, grams carbohydrates, fat, protein, alcohol).
Time Frame
Pre-intervention (week 0) and End Training (weeks 10-12)
Title
Pre-post intervention changes in Ghrelin plasma levels
Description
Participants will provide a fasting blood sample collected in ethylenediaminetetraacetic acid (EDTA)-coated and serum tubes. Changes in acylated Ghrelin will be measured via enzyme-linked immunosorbent assay (ELISA).
Time Frame
Pre-intervention (week 0) and End Training (weeks 10-12)
Title
Pre-post intervention changes in glucagon-like peptide 1 (GLP-1) plasma levels
Description
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in GLP-1 concentrations will be measured via ELISA.
Time Frame
Pre-intervention (week 0) and End Training (weeks 10-12)
Title
Pre-post intervention changes in Ghrelin concentrations
Description
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in Ghrelin concentrations will be measured via ELISA.
Time Frame
Pre-intervention (week 0) and End Training (weeks 10-12)
Title
Pre-post intervention changes in irisin concentrations
Description
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in irisin concentrations will be measured via ELISA.
Time Frame
Pre-intervention (week 0) and End Training (weeks 10-12)
Title
Pre-post intervention changes in myostatin plasma levels
Description
Participants will provide a fasting blood sample collected in EDTA-coated and serum tubes. Changes in myostatin levels will be measured via ELISA.
Time Frame
Pre-intervention (week 0) and End Training (weeks 10-12)
Title
Change in relative reinforcing value (RRV) of physical activity
Description
RRV of physical activity will be assessed by evaluating the number of responses (mouse button presses) a subject is willing to complete to gain access to physical activity or a sedentary alternative.
Time Frame
Pre-intervention (week 0) and End Training (weeks 10-12)
Title
Change in minutes of sedentary behavior, as assessed by activity tracker
Description
Minutes of sedentary behavior (non-exercise activity) will be assessed by having participants wear an Actigraph accelerometer for 7 days (minimum 10 hours per day) on the right hip.
Time Frame
Pre-intervention (week 0) and End Training (weeks 10-12)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
18 to 40 years old
BMI of 25.0 - 35 kg/m2
willing to consent to study conditions
not taking medications that affects energy expenditure or eating
not using tobacco or nicotine products
no food allergies or limitations to eating certain food that would prohibit them from eating the study foods
not be dieting to lose weight
no major health problems
cannot have known cardiovascular, pulmonary or metabolic disease
cannot be regularly exercising in an aerobic manner more than twice per week
must have a liking of at least 5 out of 10 for 75% of the study foods
Exclusion Criteria:
< 18 or > 40 years old
BMI < 25 or >35 kg/m2
currently pregnant or trying to become pregnant, or lactating
currently using tobacco or nicotine
taking medication that affects energy expenditure or eating
food allergies to foods used in the study
regularly exercising in an aerobic manner more than twice per week
major health problems
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James Roemmich, PhD
Organizational Affiliation
USDA GFHNRC
Official's Role
Principal Investigator
Facility Information:
Facility Name
USDA Grand Forks Human Nutrition Reserach Center
City
Grand Forks
State/Province
North Dakota
ZIP/Postal Code
58203
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Exercise and Weight Control
We'll reach out to this number within 24 hrs